SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas Corp is trending due to news of a potential U.S. government stake in the company, fueling speculation of a short squeeze and long-term growth. Community members are actively discussing potential price targets and the significance of securing domestic lithium supply chains. The focus remains on the implications for national security and the electric vehicle market.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is trending due to excitement surrounding upcoming Bluebird satellite launches, with the first potentially shipping to India as early as next week. The community is actively discussing potential launch dates and the impact on future coverage. Additionally, chatter about a potential large investment from Carlos Slim is circulating, further fueling investor interest.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending amid discussions surrounding its recent earnings report, with the community debating whether the results justify the stock's performance. While some highlight the company's turnaround and potential for growth under its new CEO, others express concerns about tariff headwinds and decreasing margins. Community members are closely watching for upgrades and potential movement above key resistance levels.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its association with weed culture and digital freedom. Active community members are emphasizing growth and the power to rewrite the future. Some users are pointing out a potential collaboration with $UPDOG.X.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal ($PYPL) is experiencing significant volatility, with community discussions focusing on a recent sharp decline despite positive news and a Google partnership; some speculate about market manipulation and potential for a short squeeze. Community members express frustration with the stock's inability to sustain gains, while others remain optimistic about buybacks, growth initiatives, and a potential takeover. Overall, sentiment is mixed, with some seeing a value opportunity and others expressing deep disappointment.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DKNG is trending due to concerns about increasing competition from prediction markets like Kalshi and Robinhood, which are seeing high trading volumes, especially in states where sports betting is not yet legal. The community is debating whether these platforms pose a significant threat to DraftKings' market share, and some express frustration with the company's management and perceived lack of innovation in response to this evolving landscape. Despite partnerships, some investors believe DraftKings needs to actively participate in the prediction market space.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as community members actively engage in the classic 'What's UpDog?' joke, celebrating its presence on the Solana network. Many are pointing out the low cost to become an UpDog millionaire. The community highlights that the token is listed on Jupiter and emphasizes its long-term presence in the meme coin space.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending after announcing a deal to acquire Metsera, a company focused on developing treatments for obesity, signaling a renewed push into the weight loss market. Community discussions revolve around the deal's potential impact on Pfizer's growth and its competitive positioning against other players in the sector. Some traders are speculating about potential follow-on effects for other companies in the weight loss space.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending due to strategic AI partnerships with Nvidia, OpenAI, and Snowflake, sparking excitement about its agentic automation platform. The community is discussing the potential for a short squeeze and comparing PATH to other AI stocks. Some investors are citing the company's strong financial health and zero debt as reasons for optimism.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as the community discusses Elon Musk canceling his subscription and a potential tariff on foreign films. Some traders are pointing to unusual options activity, while others are debating the impact of political ideologies on the platform. The stock's price movement and potential support levels are also being closely watched.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of LAVA Therapeutics (LVTX) declined 8% in the pre-market session on Tuesday after the company canceled the Extraordinary General Meeting of shareholders scheduled to occur today.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/09/30/3158434/0/en/LAVA-Therapeutics-to-Move-Extraordinary-General-Meeting-to-Early-November-2025.html">said</a> that it canceled the meeting to consider and approve certain matters related to its proposed transaction with XOMA Royalty Corporation (XOMA). XOMA announced in August that it will acquire LAVA for between $1.16 and $1.24 per share in cash, in addition to a contingent value right per share. The deal is expected to close in the fourth quarter (Q4) of 2025.The company said on Tuesday that it is canceling the meeting to continue discussions with XOMA concerning its estimated cash forecast and the consideration payable to the company’s shareholders in the transaction.LAVA also noted that both parties remain committed to completing the transaction by the fourth quarter.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/LVTX">LVTX stock</a> rose from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.“We are committed to closing this transaction and look forward to working collaboratively with the LAVA team to further define LAVA’s cash forecast in an effort to close this transaction in an expeditious manner,” said XOMA CEO Owen Hughes.LAVA said on Tuesday that it expects to reconvene the shareholder meeting by early November. The date will be ascertained at a later date, and shareholders who have voted will have to cast their votes again on the matters proposed, it added.LVTX stock is up 69% this year but down approximately 3% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/chainlink-swift-advance-blockchain-integration-for-ubs-tokenized-funds/chDD4dRR3Bj">Chainlink, Swift Advance Blockchain Integration For UBS Tokenized Funds</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

LAVA Therapeutics Stock Slips 9% Pre-Market – Here’s Why The Company Canceled Its Shareholder Meeting

The firm stated it canceled the meeting to consider and approve certain matters related to its proposed transaction with XOMA Royalty Corporation. 

Equity

The firm stated it canceled the meeting to consider and approve certain matters related to its proposed transaction with XOMA Royalty Corporation. 


Does XOMA Royalty (XOMA) Have the Potential to Rally 85.34% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 85.3% in XOMA Royalty (XOMA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Predict an 86.05% Upside in XOMA Royalty (XOMA): Here's  What You Should Know

The mean of analysts' price targets for XOMA Royalty (XOMA) points to an 86.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now

After losing some value lately, a hammer chart pattern has been formed for XOMA Royalty (XOMA), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Mural Oncology PLC (MURA) and XOMA Royalty Corporation (XOMA) announced on Wednesday that they have entered into a definitive agreement under which a unit of XOMA will acquire Mural for cash.Under the <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.muraloncology.com/news-releases/news-release-details/mural-oncology-announces-entry-agreement-be-acquired-xra-5-corp">deal</a>, each Mural Shareholder would receive a cash price of between $2.035 and $2.24 per share. The base cash price represents a premium of approximately 13.1% to Mural’s closing share price of $1.80 on Tuesday. The additional price per share of up to $0.205 will be paid if Mural’s closing net cash exceeds estimates.MURA stock jumped 14% in the premarket session at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MURA">Mural</a> jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘high’ levels. Meanwhile, retail sentiment around <a href="https://stocktwits.com/symbol/XOMA">XOMA</a> fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours.Mural's board of directors said that they have determined the acquisition and cash offer by XOMA, a biotechnology royalty aggregator, is in the best interest of all Mural shareholders. The board approved the acquisition and recommended that Mural shareholders vote in favor.The acquisition will be subject to the satisfaction of closing conditions, including approval by Mural shareholders. Excluding additional price per share, the deal values Mural at about $36.2 million.Mural Oncology announced plans to explore strategic alternatives in April after discontinuing all clinical development of Nemvaleukin. The decision followed data from a late-stage trial where Nemvaleukin in combination with Pembrolizumab did not achieve the primary endpoint of a statistically significant improvement in overall survival versus chemotherapy in platinum-resistant ovarian cancer. The company also saw no positive results from a mid-stage study of the drug in mucosal and cutaneous melanoma.MURA stock is down by 44% this year and over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-freezes-hiring-to-cut-costs-says-report/chsinAURdhO">Novo Nordisk Freezes Hiring To Cut Costs, Says Report: Retail Sees Stock Surpassing $100-Mark In A Year</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mural Oncology To Be Acquired By XOMA Royalty

The Mural board of directors said that they have determined the acquisition and cash offer by XOMA is in the best interest of all its shareholders. 

How Much Upside is Left in XOMA Royalty (XOMA)? Wall Street Analysts Think 106.15%

The average of price targets set by Wall Street analysts indicates a potential upside of 106.2% in XOMA Royalty (XOMA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

XOMA Royalty (XOMA) Q2 Earnings and Revenues Surpass Estimates

XOMA Royalty (XOMA) delivered earnings and revenue surprises of +500.00% and +39.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +22.43% and +4.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Novavax (NVAX) Q2 Earnings and Revenues Top Estimates

Novavax (NVAX) delivered earnings and revenue surprises of +985.71% and +102.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Shares of Turnstone Biologics Corp. (TSBX) jumped over 5% on Friday morning after the company said that it has entered into a definitive merger agreement whereby XOMA Royalty Corporation (XOMA) will acquire Turnstone.As per the <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.xoma.com/news-events/press-releases/detail/477/turnstone-biologics-corp-enters-into-agreement-to-be">agreement</a>, XOMA Royalty will acquire Turnstone for $0.34 in cash per share of Turnstone common stock plus one non-transferable contingent value right.The upfront payment of $0.34 represents a 2.4% upside to the stock’s closing price on Thursday.<a href="https://stocktwits.com/symbol/TSBX">Turnstone Biologics</a> is a biotechnology company developing new medicines to treat and cure patients with solid tumors. Its Board of Directors has unanimously determined that the acquisition by XOMA Royalty is in the best interests of all Turnstone stockholders and has approved the merger agreement and related transactions, the company said. &nbsp;The merger transaction is expected to close in August 2025.<a href="https://stocktwits.com/symbol/XOMA">XOMA Royalty</a>, meanwhile, is a biotechnology royalty aggregator – &nbsp;a company that acquires the rights to future royalties and milestone payments from biopharmaceutical companies – with over 120 assets. Royalty aggregators typically provide a form of non-dilutive financing for biotech companies, allowing them to access capital without selling equity or taking on debt.Turnstone had cash, cash equivalents, and short-term investments of only $21.9 million as of the end of the first quarter (Q1). The company’s net loss in the three months through the end of March this year was $11.8 million, compared to a net loss of $19.6 million for the same period in 2024.On Stocktwits, retail sentiment around XOMA jumped from ‘bearish’ to ‘neutral’ territory over the past 24 hours while sentiment around TSBX slumped from ‘neutral’ to ‘bearish’.<figure class="image"><img style="aspect-ratio:1258/128;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_27_at_11_05_04_AM_png_dd0f3102eb.webp" alt="XOMA's Sentiment Meter and Message Volume as of 11:05 a.m. ET on June 27, 2025 | Source: Stocktwits" width="1258" height="128"><figcaption>XOMA's Sentiment Meter and Message Volume as of 11:05 a.m. ET on June 27, 2025 | Source: Stocktwits</figcaption></figure><figure class="image"><img style="aspect-ratio:1252/128;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_27_at_11_05_23_AM_png_688b06d81a.webp" alt="TSBX's Sentiment Meter and Message Volume as of 11:05 a.m. ET on June 27, 2025 | Source: Stocktwits" width="1252" height="128"><figcaption>TSBX's Sentiment Meter and Message Volume as of 11:05 a.m. ET on June 27, 2025 | Source: Stocktwits</figcaption></figure>While XOMA is up by 5% this year, TSBX is down by about 30%.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-ropes-in-former-exec-of-gm-cruise-as-head-of-autonomy/chmgyoCRRIU">Tesla Ropes In Former Exec Of GM’s Failed Self-Driving Unit As Head Of Autonomy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Turnstone Biologics To Merge With Biotech Royalty Aggregator XOMA, But Retail Sentiment Slumps

XOMA Royalty will acquire Turnstone for $0.34 in cash per share of Turnstone common stock plus one non-transferable contingent value right.

XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets that provides right to future potential royalty and milestone payments. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

XOMA Royalty Corp.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

XOMA
XOMA Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest XOMA News

XOMA XOMA Corp